CTRI/2024/05/068109尚未招募3 期
Evaluation of the effectiveness of photobiomodulation therapy as an alternative to topical anesthesia for extraction of physiologically mobile teeth (grade III ) : An Observational Study - NI
Dr Sandra maria Enchackal0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. 6-12 year-old children requiring extraction of primary physiologic mobile tooth (grade III mobile)
- •2. Co-operative children with Frankl behaviour scale of 3/4
- •3. Participants with informed consent of parents or assent (in older children)
排除标准
- •Children with special needs and systemic diseases or bleeding disorder
- •2. Children with known allergic reactions to topical anesthesia
- •3. Children who had analgesics for a minimum of 24hrs prior to the treatment
研究者
相似试验
招募中
2 期
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III.HIV InfectionsHuman Immunodeficiency VirusHIVLentiviruses InfectionsRetroviridae InfectionsRNA Viruses InfectionsSexually Transmitted Diseases, ViralImmunologic Deficiency SyndromesImmune System DiseasesEnvironmental IllnessVirus DiseasesSexually Transmitted DiseasesRPCEC00000288ational Center of Bioproducts (BIOCEN)198
尚未招募
不适用
Biomodulina T in pediatric septic shock. Exploratory studySystemic Inflammatory Response SyndromeShock, SepticShockPathologic ProcessesPediatricsSeptic shockSepsisRPCEC00000327Centro Nacional de Biopreparados (BioCen)60
招募中
不适用
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory studyCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusDisease PreventionAgingRPCEC00000348ational Center for Bioproducts (BioCen).60
尚未招募
不适用
Clinical study to evaluate Pain perception after Interproximal reduction Using Neuromodulation Device .CTRI/2022/10/046373Anu Nain
招募中
3 期
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase IIIThymus hypoplasiaThymic HypoplasiaThymus Gland /abnormalitiesRPCEC00000247Center National of Bioproducts (BioCen)60
